Literature DB >> 15976397

Thresholds for normal blood pressure and serum cholesterol.

Steinar Westin, Iona Heath.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15976397      PMCID: PMC558444          DOI: 10.1136/bmj.330.7506.1461

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  8 in total

1.  General practice workload implications of the national service framework for coronary heart disease: cross sectional survey.

Authors:  J Hippisley-Cox; M Pringle
Journal:  BMJ       Date:  2001-08-04

2.  Preventing cardiovascular disease in primary care.

Authors:  L Toop; D Richards
Journal:  BMJ       Date:  2001-08-04

3.  Open letter disputes WHO hypertension guidelines

Authors: 
Journal:  BMJ       Date:  1999-04-03

4.  Is opportunistic disease prevention in the consultation ethically justifiable?

Authors:  Linn Getz; Johann A Sigurdsson; Irene Hetlevik
Journal:  BMJ       Date:  2003-08-30

Review 5.  Communicating the risk reduction achieved by cholesterol reducing drugs.

Authors:  J A Skolbekken
Journal:  BMJ       Date:  1998-06-27

6.  Ethical dilemmas arising from implementation of the European guidelines on cardiovascular disease prevention in clinical practice. A descriptive epidemiological study.

Authors:  Linn Getz; Anna Luise Kirkengen; Irene Hetlevik; Solfrid Romundstad; Johann A Sigurdsson
Journal:  Scand J Prim Health Care       Date:  2004-12       Impact factor: 2.581

7.  Atenolol in hypertension: is it a wise choice?

Authors:  Bo Carlberg; Ola Samuelsson; Lars Hjalmar Lindholm
Journal:  Lancet       Date:  2004 Nov 6-12       Impact factor: 79.321

8.  European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice.

Authors:  Guy De Backer; Ettore Ambrosioni; Knut Borch-Johnsen; Carlos Brotons; Renata Cifkova; Jean Dallongeville; Shah Ebrahim; Ole Faergeman; Ian Graham; Giuseppe Mancia; Volkert Manger Cats; Kristina Orth-Gomér; Joep Perk; Kalevi Pyörälä; José L Rodicio; Susana Sans; Vedat Sansoy; Udo Sechtem; Sigmund Silber; Troels Thomsen; David Wood
Journal:  Eur Heart J       Date:  2003-09       Impact factor: 29.983

  8 in total
  14 in total

1.  Big pharma: a story of success in a market economy.

Authors:  Joao Calinas-Correia
Journal:  Med Health Care Philos       Date:  2013-05

2.  A taxonomy of general practice.

Authors:  Kieran Sweeney; Iona Heath
Journal:  Br J Gen Pract       Date:  2006-05       Impact factor: 5.386

3.  Model of hidden heterogeneity in longitudinal data.

Authors:  Anatoli I Yashin; Konstantin G Arbeev; Igor Akushevich; Alexander Kulminski; Lucy Akushevich; Svetlana V Ukraintseva
Journal:  Theor Popul Biol       Date:  2007-09-18       Impact factor: 1.570

4.  The Quality and Outcomes Framework: what have you done to yourselves?

Authors:  Dee Mangin; Les Toop
Journal:  Br J Gen Pract       Date:  2007-06       Impact factor: 5.386

5.  Screening strategies for chronic kidney disease in the general population: follow-up of cross sectional health survey.

Authors:  Stein I Hallan; Ketil Dahl; Cecilia M Oien; Diana C Grootendorst; Arne Aasberg; Jostein Holmen; Friedo W Dekker
Journal:  BMJ       Date:  2006-10-24

6.  How Genes Modulate Patterns of Aging-Related Changes on the Way to 100: Biodemographic Models and Methods in Genetic Analyses of Longitudinal Data.

Authors:  Anatoliy I Yashin; Konstantin G Arbeev; Deqing Wu; Liubov Arbeeva; Alexander Kulminski; Irina Kulminskaya; Igor Akushevich; Svetlana V Ukraintseva
Journal:  N Am Actuar J       Date:  2016-06-22

Review 7.  How the effects of aging and stresses of life are integrated in mortality rates: insights for genetic studies of human health and longevity.

Authors:  Anatoliy I Yashin; Konstantin G Arbeev; Liubov S Arbeeva; Deqing Wu; Igor Akushevich; Mikhail Kovtun; Arseniy Yashkin; Alexander Kulminski; Irina Culminskaya; Eric Stallard; Miaozhu Li; Svetlana V Ukraintseva
Journal:  Biogerontology       Date:  2015-08-18       Impact factor: 4.277

8.  Genetic model for longitudinal studies of aging, health, and longevity and its potential application to incomplete data.

Authors:  Konstantin G Arbeev; Igor Akushevich; Alexander M Kulminski; Liubov S Arbeeva; Lucy Akushevich; Svetlana V Ukraintseva; Irina V Culminskaya; Anatoli I Yashin
Journal:  J Theor Biol       Date:  2009-02-04       Impact factor: 2.691

9.  Which population groups should be targeted for cardiovascular prevention? A modelling study based on the Norwegian Hordaland Health Study (HUSK).

Authors:  Mette Brekke; Magne Rekdal; Jørund Straand
Journal:  Scand J Prim Health Care       Date:  2007-06       Impact factor: 2.581

10.  Prevalence of polypharmacy and drug interaction among hospitalized patients: opportunities and responsabilities in pharmaceutical care.

Authors:  Edisa Trumic; Nurka Pranjic; Lejla Begic; Fahir Bečić
Journal:  Mater Sociomed       Date:  2012
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.